Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine

Zuzana Berrong; Shamim Ahmad; Rasha Abu Eid; Abdeljabar  El-Andaloussi; Tanusree Sen; Ross Stewart; Scott A. Hammond; Rajeev  Shrimali; Mikayel Mkrtichyan; Samir N Khleif

doi:10.1186/2051-1426-2-S3-P226

Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine

Zuzana Berrong, Shamim Ahmad, Rasha Abu Eid, Abdeljabar El-Andaloussi , Tanusree Sen, Ross Stewart, Scott A. Hammond, Rajeev Shrimali, Mikayel Mkrtichyan, Samir N Khleif

Dental Education

Research output: Chapter in Book/Report/Conference proceeding › Published conference contribution

Original language	English
Title of host publication	Journal for ImmunoTherapy of Cancer
Subtitle of host publication	Abstracts of the 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)
Publisher	BioMed Central
Pages	226
Number of pages	1
Volume	2
Edition	Suppl 3
DOIs	https://doi.org/10.1186/2051-1426-2-S3-P226
Publication status	Published - 6 Nov 2014
Event	Society for Immunotherapy of Cancer 29th Annual Meeting - National Harbor, Maryland, United States Duration: 6 Nov 2014 → 9 Nov 2014

Conference

Conference	Society for Immunotherapy of Cancer 29th Annual Meeting
Abbreviated title	SITC
Country/Territory	United States
City	Maryland
Period	6/11/14 → 9/11/14

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/2051-1426-2-S3-P226Licence: CC BY

Cite this

Berrong, Z., Ahmad, S., Abu Eid, R., El-Andaloussi , A., Sen, T., Stewart, R., Hammond, S. A., Shrimali, R., Mkrtichyan, M., & Khleif, S. N. (2014). Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine. In Journal for ImmunoTherapy of Cancer : Abstracts of the 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC) (Suppl 3 ed., Vol. 2, pp. 226). BioMed Central. https://doi.org/10.1186/2051-1426-2-S3-P226

Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine. / Berrong, Zuzana; Ahmad, Shamim; Abu Eid, Rasha et al.
Journal for ImmunoTherapy of Cancer : Abstracts of the 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC). Vol. 2 Suppl 3. ed. BioMed Central, 2014. p. 226.

Research output: Chapter in Book/Report/Conference proceeding › Published conference contribution

Berrong, Z, Ahmad, S, Abu Eid, R, El-Andaloussi , A, Sen, T, Stewart, R, Hammond, SA, Shrimali, R, Mkrtichyan, M & Khleif, SN 2014, Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine. in Journal for ImmunoTherapy of Cancer : Abstracts of the 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC). Suppl 3 edn, vol. 2, BioMed Central, pp. 226, Society for Immunotherapy of Cancer 29th Annual Meeting, Maryland, United States, 6/11/14. https://doi.org/10.1186/2051-1426-2-S3-P226

Berrong Z, Ahmad S, Abu Eid R, El-Andaloussi A, Sen T, Stewart R et al. Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine. In Journal for ImmunoTherapy of Cancer : Abstracts of the 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC). Suppl 3 ed. Vol. 2. BioMed Central. 2014. p. 226 doi: 10.1186/2051-1426-2-S3-P226

@inproceedings{249fa650baa94b918b93c57cc847b8a8,

title = "Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine",

author = "Zuzana Berrong and Shamim Ahmad and {Abu Eid}, Rasha and Abdeljabar El-Andaloussi and Tanusree Sen and Ross Stewart and Hammond, {Scott A.} and Rajeev Shrimali and Mikayel Mkrtichyan and Khleif, {Samir N}",

year = "2014",

month = nov,

day = "6",

doi = "10.1186/2051-1426-2-S3-P226",

language = "English",

volume = "2",

pages = "226",

booktitle = "Journal for ImmunoTherapy of Cancer",

publisher = "BioMed Central",

address = "United Kingdom",

edition = "Suppl 3",

note = "Society for Immunotherapy of Cancer 29th Annual Meeting, SITC ; Conference date: 06-11-2014 Through 09-11-2014",

}

TY - GEN

T1 - Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine

AU - Berrong, Zuzana

AU - Ahmad, Shamim

AU - Abu Eid, Rasha

AU - El-Andaloussi , Abdeljabar

AU - Sen, Tanusree

AU - Stewart, Ross

AU - Hammond, Scott A.

AU - Shrimali, Rajeev

AU - Mkrtichyan, Mikayel

AU - Khleif, Samir N

PY - 2014/11/6

Y1 - 2014/11/6

U2 - 10.1186/2051-1426-2-S3-P226

DO - 10.1186/2051-1426-2-S3-P226

M3 - Published conference contribution

VL - 2

SP - 226

BT - Journal for ImmunoTherapy of Cancer

PB - BioMed Central

T2 - Society for Immunotherapy of Cancer 29th Annual Meeting

Y2 - 6 November 2014 through 9 November 2014

ER -